Evidence map

ReviewHeliyon2022

Cisplatin for cancer therapy and overcoming chemoresistance.

Ranmali Ranasinghe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

91 papers cite itlatest 60 shown

2022
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 36158077